top of page
< Back

WHERE DOES THE MONEY GO?

A NEW IMMUNOTHERAPY APPROACH TO TARGET TRIPLE-NEGATIVE BREAST CANCER

2021 - 2023

INSTITUTION:

Queensland Institute of Medical Research Berghofer

 

CHIEF RESEARCHER:

Prof. Kum Kum Khanna

This research will improve our knowledge about the factors that inhibit growth and recurrence of breast cancer, which is critical to unlocking better treatment strategies. It holds promise for rapid translation to the clinic given encouraging recent successes with immunotherapy approaches for hard-to-treat cancers.

Triple Negative Breast Cancers (TNBCs) are often aggressive, often spread to the brain and lungs, and account for the majority of female cancer-related deaths globally. To improve on the efficacy of immunotherapy and increase the percentage of patients who benefit from an approach that targets exhausted immune cells in TNBCs, Prof. Kum Kum Khanna has identified and characterised a new vaccine target. CEP55 is a tumour specific antigen. Researchers have identified peptides derived from CEP55 that can stimulate the generation of cytotoxic T lymphocytes (CTLs) that can recognise and kill breast cancer cells. This research involves testing the feasibility and efficacy of a novel CEP55-based peptide vaccine by exploiting a new cancer vaccine delivery platform developed by collaborators Prof. Riccardo Dolcetti and Dr. Roberta Mazzieri.

A NEW IMMUNOTHERAPY APPROACH TO TARGET TRIPLE-NEGATIVE BREAST CANCER

FLANKS FOR JOINING!

-  JOIN OUR MAILING LIST - 

Love Your Sister is Australia's hardest-working cancer vanquishing charity, and since its inception in 2012 has raised $20M for medical research.

 

Founded by Gold Logie-winning actor and Victorian Australian of the Year 2018, Samuel Johnson OAM, Love Your Sister is a million-strong village of everyday Aussies committed to vanquishing cancer with hard science and the best new technologies. Love Your Sister supports precision treatment for ALL cancer patients, whatever the cancer, regardless of location, age, income, or status. We strive for the right treatment for every cancer patient, first time, every time.

Love Your Sister pr
oudly passes 100% of all donations received to research.  No skimming. No admin. No BS!

LoveYourSister Corp_2017_Simple2_white.p
acnc-logo-300x300.png

CONTACT US     FAQs 

LOVE YOUR SISTER ABN: 92 770 192 934

© 2024 by LOVE YOUR SISTER

bottom of page